Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-26

Clinical Trial Update: Reminiscence, Anxiety and Early Alzheimer's Disease [NA]

View source ↗

Summary

Clinical trial investigating reminiscence and anxiety in early Alzheimer's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Emory University | Conditions: Alzheimer's Disease | NA | Status: WITHDRAWN